| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00259-006-0300-6 |
| P698 | PubMed publication ID | 17136539 |
| P50 | author | Agata Bialoszewska | Q79394812 |
| P2093 | author name string | Tomasz Grzela | |
| Robert Brawura-Biskupski-Samaha | |||
| P2860 | cites work | C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest | Q22008681 |
| Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 | Q24673055 | ||
| HMG-CoA reductase inhibitors and P-glycoprotein modulation | Q28360140 | ||
| DNA (cytosine) methyltransferase overexpression is associated with acquired drug resistance of murine neuroblastoma cells. | Q31922535 | ||
| Nuclear medicine therapy of pheochromocytoma and paraganglioma | Q33872243 | ||
| Tumor markers in neuroendocrine tumors | Q34001693 | ||
| Peptide receptor imaging and therapy | Q34064340 | ||
| P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype | Q34142289 | ||
| Somatostatin analogs in oncology: a look to the future | Q34199379 | ||
| Active transport of imatinib into and out of cells: implications for drug resistance | Q34341750 | ||
| Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma | Q34507181 | ||
| Endocrine tumors of the digestive tract and pancreas: histogenesis, diagnosis and molecular basis | Q34569319 | ||
| Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings | Q34608887 | ||
| Experience with indium-111 and yttrium-90-labeled somatostatin analogs | Q34779912 | ||
| The pathophysiological consequences of somatostatin receptor internalization and resistance | Q35067256 | ||
| Alterations in the apoptotic machinery and their potential role in anticancer drug resistance | Q35567264 | ||
| The diagnosis and medical management of advanced neuroendocrine tumors. | Q35794419 | ||
| Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors | Q35831062 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| Organic cation transporters are determinants of oxaliplatin cytotoxicity. | Q37416089 | ||
| Regression of melanoma in a murine model by RLIP76 depletion | Q38315672 | ||
| Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin | Q40410738 | ||
| Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging | Q40414963 | ||
| Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues | Q40642381 | ||
| RLIP76 is a major determinant of radiation sensitivity | Q46604639 | ||
| Expression analysis of multidrug resistance associated genes in neuroblastomas. | Q48150693 | ||
| Nuclear medicine 2020. | Q53545662 | ||
| P-glycoprotein expression influences the result of 99mTc-MIBI scintigraphy in tertiary hyperparathyroidism. | Q53851214 | ||
| Persisted/recurrent hyperparathyroidism associated with development of multi-drug resistance phenotype and proliferation of parathyroid transplants. | Q53885119 | ||
| The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors. | Q54155307 | ||
| OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib | Q59236733 | ||
| Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells | Q73154744 | ||
| Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin | Q73253458 | ||
| Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma | Q73331968 | ||
| Expression of multidrug resistance-related markers in primary neuroblastoma | Q80585813 | ||
| P433 | issue | 4 | |
| P1104 | number of pages | 4 | |
| P304 | page(s) | 444-447 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
| P1476 | title | Nuclear medicine in the treatment of neuroendocrine tumours--problems and perspectives | |
| P478 | volume | 34 |
Search more.